Form D · Pharmaceuticals

K-V Pharmaceutical Co

Chesterfield, MO · CIK 0000057055

Offering snapshot reported Sep 25, 2013 · SEC filing

Reported sold
$261M
Offering amount: $261M
Investors reported
28
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 6, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 25, 2013Initial$260,877,100No comparison28SEC filing
Jun 18, 2012Initial$210,000No comparison1SEC filing
Apr 1, 2011Initial$225,000,000No comparison104SEC filing
Mar 4, 2011Initial$32,337,500No comparison12SEC filing
Dec 6, 2010Initial$7,552,506No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-203543

Source: Form D, filed Sep 25, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert E. Baldini Director
Gregory S. Bentley Director, Executive
Patrick J Christmas Executive
Gregory J Divis Director, Executive
Gregory J. Divis, Jr. Executive
Mark A. Dow Director
Eric Haron Director
David S. Hermelin Director
Joseph D. Lehrer Director
Joe Mc Ginnis Director
Thomas S Mc Hugh Executive
Steve Nielson Director
David Sidransky Director
Jonathan Siegel Director
Ana I. Stancic Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
16640 Chesterfield Grove Road Suite 200
Chesterfield, MO, 63005